Nomura Asset Management International’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Nomura Asset Management International's IONS Position: Q2 2026 in Review
Nomura Asset Management International increased its Ionis Pharmaceuticals (IONS) stake by 66% in Q2 2026, buying an estimated $38.8M and bringing the position to 1,300,392 shares worth $103M. The position accounts for 0.15% of the portfolio, ranked #141.
Nomura Asset Management International first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Nomura Asset Management International held 1,300,392 shares of Ionis Pharmaceuticals worth $103M as of Q2 2026.
- Nomura Asset Management International bought 515,111 Ionis Pharmaceuticals shares in Q2 2026, an estimated $38.8M.
- Ionis Pharmaceuticals made up 0.15% of Nomura Asset Management International's portfolio in Q2 2026, its #141 holding.
- Nomura Asset Management International first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.